Abstract Objective: To analyze the influence of single port laparoscopic surgery for treating women with benign ovarian tumor on their ovarian function recovery. Methods: The clinical data of 60 women with benign ovarian tumor from March 2015 to March 2018 were collected and divided into two groups. The women in the control group were treated by porous laparoscopic surgery, and the women in the observation group were treated by single port laparoscopic surgery. The clinical efficacy of women in the two groups was analyzed. Results: The postoperative exhaust time (13.28±1.31 h) and the hospitalization time (2.61±1.45 d) of women in the observation group were significant shorter than those of women in the control group, but the operation time (63.26±8.05min ) of women in the observation group was significant longer than that of women in the control group (P>0.05). The levels of Beta endorphin, preoperative cortisol (Cor), growth hormone (HGH), and tumor necrosis factor alpha (TNF α), and the levels of immunologic function indexes (CD3+, CD4+, CD8+, and CD4+/CD8+)) of women in the observation group were significant better than those of women in the control group (P>0.05). There were no significant different in the intraoperative blood loss volume, and levels of estradiol (E2), follicle stimulating hormone (FSH), and luteinizing hormone (LH) of women after operation, and the situation of menstrual recovery of women 3 months after operation between the two groups (P>0.05). Conclusion: Single port laparoscopic surgery for treating women with benign ovarian tumor has less influence on the immune function and ovarian function of women.
|
|
|
|
|